Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/200434
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

TRP Channels: Current Perspectives in the Adverse Cardiac Remodeling

AutorFalcón, Debora CSIC ORCID; Galeano-Otero, Isabel; Calderón-Sánchez, Eva CSIC; Toro, Raquel del CSIC ORCID; Martín-Bórnez, Marta CSIC ORCID CVN; Rosado, Juan A.; Hmadcha, Abdelkrim CSIC ORCID; Smani, Tarik CSIC ORCID
Palabras claveCalcium
TRP channels
Cardiac remodeling
Hypertrophy
Fibrosis
Conduction disorders
Fecha de publicación1-mar-2019
EditorFrontiers Media
CitaciónFrontiers in Physiology 10: 159 (2019)
ResumenCalcium is an important second messenger required not only for the excitation-contraction coupling of the heart but also critical for the activation of cell signaling pathways involved in the adverse cardiac remodeling and consequently for the heart failure. Sustained neurohumoral activation, pressure-overload, or myocardial injury can cause pathologic hypertrophic growth of the heart followed by interstitial fibrosis. The consequent heart’s structural and molecular adaptation might elevate the risk of developing heart failure and malignant arrhythmia. Compelling evidences have demonstrated that Ca2+ entry through TRP channels might play pivotal roles in cardiac function and pathology. TRP proteins are classified into six subfamilies: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPML (mucolipin), and TRPP (polycystin), which are activated by numerous physical and/or chemical stimuli. TRP channels participate to the handling of the intracellular Ca2+ concentration in cardiac myocytes and are mediators of different cardiovascular alterations. This review provides an overview of the current knowledge of TRP proteins implication in the pathologic process of some frequent cardiac diseases associated with the adverse cardiac remodeling such as cardiac hypertrophy, fibrosis, and conduction alteration.
Versión del editorhttps://doi.org/10.3389/fphys.2019.00159
URIhttp://hdl.handle.net/10261/200434
DOI10.3389/fphys.2019.00159
E-ISSN1664-042X
Aparece en las colecciones: (IBIS) Artículos
(CABIMER) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
fphys-10-00159.pdf1,2 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

34
checked on 14-abr-2024

SCOPUSTM   
Citations

47
checked on 16-abr-2024

WEB OF SCIENCETM
Citations

44
checked on 25-feb-2024

Page view(s)

181
checked on 18-abr-2024

Download(s)

121
checked on 18-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons